Bluebird Bio
World Rank (Jan-05-2024)
16,197
Market Cap (Jan-05-2024)
0.279 Billion USD
World Rank (Jul-30-2023)
13,845
Market Cap (Jul-30-2023)
0.420 Billion USD
World Rank (Dec-25-2022)
11,315
Market Cap (Dec-25-2022)
0.595 Billion USD
World Rank (Jan-07-2022)
11,640
Market Cap (Jan-07-2022)
0.67 Billion USD
Annual Revenue in USD
3 Million USD
Annual Net Income in USD
-819 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Company Profile
Bluebird Bio is a Gene Therapy and Pharmaceutical company. It is working toward four potential product approvals by 2022 and a pipeline ready to tackle a range of severe diseases. The company is Powered by multiple labs, in house lentiviral vector manufacturing capabilities and future drug product production and it push to find answers for the people who need them by exploring the cutting edge spectrum of gene therapy. The headquarters is in USA.
Company Website